GlobeNewswire Inc.··NaOpus Genetics to Present Phase 3 Presbyopia Data at Major Eye Surgery Conference
Opus Genetics will present three abstracts at ASCRS 2026, including Phase 3 results for phentolamine ophthalmic solution treating presbyopia and mesopic vision issues.
VTRSIRDPhase 3 clinical trialgene therapy